Pere Barba

6.3k citations

90 papers · 1.6k indexed · h-index 24

Impact in

Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Transplantation top 5%

Papers in ⓘ

Hematology 46
- Hematopoietic Stem Cell Transplantation 38
- Acute Myeloid Leukemia Research 18
Transplantation 8
- Renal Transplantation Outcomes and Treatments 8

Co-authors: David Valcárcel (33 shared papers)Rodrigo Martino (34 shared papers)Jorge Sierra (27 shared papers)José Luís Piñana (21 shared papers)Salut Brunet (15 shared papers)Javier Briones (13 shared papers)Anna Sureda (10 shared papers)Guillermo Ortí (6 shared papers)
Journals: Biology of Blood and Marrow Transplantation (16 papers)Bone Marrow Transplantation (11 papers)Blood (6 papers)Cancer (3 papers)British Journal of Haematology (3 papers)
Partner nations: Spain United States Germany

In The Last Decade

Pere Barba

85 papers receiving 1.6k citations

Peers

Countries citing papers authored by Pere Barba

Since Specialization

Citations

This map shows the geographic impact of Pere Barba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pere Barba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pere Barba more than expected).

Fields of papers citing papers by Pere Barba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pere Barba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pere Barba. The network helps show where Pere Barba may publish in the future.

Co-authors

The 25 scholars most cited alongside Pere Barba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pere Barba Line = papers co-authored together Pere Barba links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL Journal for ImmunoTherapy of Cancer ·Kai Rejeski, Ariel Perez Perez, Gloria Iacoboni, Olaf Penack, Veit Bücklein, Liv Jentzsch, Dimitrios Mougiakakos, Grace Johnson, Brian Arciola, Cecilia Carpio, Viktoria Blumenberg, Eva Hoster, Lars Bullinger, Frederick L. Locke, Michael von Bergwelt‐Baildon, Andréas Mackensen, Wolfgang Bethge, Pere Barba, Michael D. Jain, Marion Subklewe	2022	91
2	Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma Cancer Medicine ·Gloria Iacoboni, Guillermo Villacampa, Núria Martínez‐Cibrián, Rebeca Bailén, Lucía López‐Corral, Jose M. Sánchez, Manuel Guerreiro, A Caballero, Alberto Mussetti, Juan‐Manuel Sancho, Rafael Hernani, Pau Abrisqueta, Carlos Solano, Anna Sureda, Javier Briones, Alejandro Martı́n, Mi Kwon, Juan Luis Reguera, Pere Barba, (unknown)	2021	81
3	Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle Frontiers in Immunology ·Benno Lickefett, Lulu Chu, Valentin Ortiz-Maldonado, Linda Warmuth, Pere Barba, Matteo Doglio, David Henderson, Michael Hudecek, Andreas Kremer, Janet L. Markman, Magdalena Nauerth, Hélène Negre, Carmen Sanges, Philipp B. Staber, Rebecca Tanzi, Julio Delgado, Dirk H. Busch, Jürgen Kuball, Maik Luu, Ulrich Jäger	2023	75
4	Invasive Aspergillosis Complicating Pandemic Influenza A (H1N1) Infection in Severely Immunocompromised Patients Clinical Infectious Diseases ·Carolina García‐Vidal, Pere Barba, Montserrat Arnán, Asunción Moreno, Isabel Ruíz-Camps, Carlota Gudiol, Josefina Ayats, Guillermo Ortí, Jordi Carratalà	2011	73
5	Comparison of Two Pretransplant Predictive Models and a Flexible HCT-CI Using Different Cut off Points to Determine Low-, Intermediate-, and High-Risk Groups: The Flexible HCT-CI Is the Best Predictor of NRM and OS in a Population of Patients Undergoing allo-RIC Biology of Blood and Marrow Transplantation ·Pere Barba, José Luís Piñana, Rodrigo Martino, David Valcárcel, Alex Amorós, Anna Sureda, Javier Briones, Julio Delgado, Salut Brunet, Jorge Sierra	2009	56
6	Early and Late Neurological Complications after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation Biology of Blood and Marrow Transplantation ·Pere Barba, José Luís Piñana, David Valcárcel, Luís Querol, Rodrigo Martino, Anna Sureda, Javier Briones, Julio Delgado, Salut Brunet, Jorge Sierra	2009	55
7	Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect Experimental Hematology ·Guillermo Ortí, Pere Barba, María Laura Fox, Olga Salamero, Francesc Bosch, David Valcárcel	2016	49
8	Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status Cancer ·Josep‐María Ribera, Olga García, Carlos Grande, Jordi Esteve, Albert Oriol, Juan Bergua, José González‐Campos, Ferran Vall‐Llovera, Mar Tormo, Jesús María Hernández‐Rivas, Daniel Fernández-García, Salut Brunet, Natalia Alonso, Pere Barba, Pilar Miralles, Andreu Llorente, Pau Montesinos, M.-J. Moreno, José‐Ángel Hernández‐Rivas, Teresa Bernal	2013	46
9	Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab Bone Marrow Transplantation ·Irene García‐Cadenas, Nerea Castillo, Rodrigo Martino, Pere Barba, Albert Esquirol, Silvana Novelli, Guillermo Ortí, Ana Garrido, Sandra Marcela Calero Saavedra, Carolina Moreno, Miquel Granell, Javier Briones, Salut Brunet, Ferrán Navarro, Isabel Ruíz-Camps, Núria Rabella, David Valcárcel, Jorge Sierra	2015	45
10	MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings Bone Marrow Transplantation ·José Luís Piñana, David Valcárcel, Francesc Fernández‐Avilés, Rodrigo Martino, Miquel Rovira, Pere Barba, Carmen Martı́nez, Salut Brunet, Anna Sureda, Enric Carreras, Jorge Sierra	2010	41
11	Study of Kidney Function Impairment after Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation. A Single-Center Experience Biology of Blood and Marrow Transplantation ·José Luís Piñana, David Valcárcel, Rodrigo Martino, Pere Barba, E. Moreno, Anna Sureda, Monica Vega, Julio Delgado, Javier Briones, Salut Brunet, Jorge Sierra	2009	41
12	Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy Annals of Hematology ·Gloria Iacoboni, Marc Simó, Guillermo Villacampa, Eva Catalá, Cecilia Carpio, Cándido Díaz‐Lagares, Ángela Vidal‐Jordana, Sabela Bobillo, Ana Marín‐Niebla, Ana Pérez, Moraima Jiménez, Pau Abrisqueta, Francesc Bosch, Pere Barba	2021	41
13	Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia Annals of Hematology ·(unknown), Juan Carlos Hernández‐Boluda, Eduardo Arellano‐Rodrigo, Francisco Cervantes, Alberto Álvarez‐Larrán, Montse Gómez, Pere Barba, María-Isabel Mata, José-Ramón González-Porras, Francisca Ferrer‐Marín, Valentín García‐Gutiérrez, Elena Magro, M.J. Moreno, Ana Kerguelen, Manuel Pérez‐Encinas, Natàlia Estrada, Rosa Ayala, Carles Besses, Arturo Pereira	2015	41
14	Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease Bone Marrow Transplantation ·Irene García‐Cadenas, I Rivera, Rodrigo Martino, Albert Esquirol, Pere Barba, Silvana Novelli, Guillermo Ortí, Javier Briones, Salut Brunet, David Valcárcel, Jorge Sierra	2016	38
15	Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols Cancer ·Jordi Ribera, Mireia Morgades, Lurdes Zamora, Pau Montesinos, Inés Gómez‐Seguí, Marta Pratcorona, Josep Sarrà, Ramón Guàrdia, Josep Nomdedéu, Mar Tormo, Joaquín Martínez‐López, Jesús María Hernández‐Rivas, José González‐Campos, Pere Barba, Lourdes Escoda, Eulàlia Genescà, Françesc Solé, Fuensanta Millá, Evarist Feliú, Josep‐María Ribera, (unknown)	2015	36
16	Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy Blood Advances ·Kai Rejeski, Andreas Burchert, Gloria Iacoboni, Pierre Sesques, Lars Fransecky, Veit Bücklein, Corinna Trenker, Rafael Hernani, Ralph Naumann, Jonas Schäfer, Viktoria Blumenberg, Christian Schmidt, Kristina Sohlbach, Michael von Bergwelt‐Baildon, Emmanuel Bachy, Pere Barba, Marion Subklewe	2022	36
17	Early and Long-Term Impaired T Lymphocyte Immune Reconstitution after Cord Blood Transplantation with Antithymocyte Globulin Biology of Blood and Marrow Transplantation ·Nerea Castillo, Irene García‐Cadenas, Pere Barba, Carme Saurina, Cristina Díaz de Heredia, Rodrigo Martino, Christelle Ferrá, Isabel Badell, Izaskun Elorza, Jorge Sierra, David Valcárcel, Sergio Querol	2016	34
18	Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization Bone Marrow Transplantation ·Isabel Sánchez‐Ortega, Sergi Querol, Maite Encuentra, Sandra Ortega, Annalisa Serra, Jorge Sánchez-Villegas, Joan-Ramon Grífols, M M Pujol-Balaguer, M Pujol-Bosch, Josep Martí, Tomás García-Cerecedo, Pere Barba, Juan‐Manuel Sancho, Albert Esquirol, Jorge Sierra, Rafael F. Duarte	2014	33
19	Checkpoint inhibitors in AML: are we there yet? British Journal of Haematology ·Arnab Ghosh, Pere Barba, Miguel‐Angel Perales	2019	33
20	Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation Score Allows a Better Stratification of High-Risk Patients Undergoing Reduced-Toxicity Allogeneic Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation ·Pere Barba, Rodrigo Martino, Josè Antonio Pérez-Simón, Francesc Fernández‐Avilés, Nerea Castillo, José Luís Piñana, Lucía López‐Anglada, Montserrat Rovira, Francesc Bosch, Enric Carreras, Lucía López‐Corral, Jorge Sierra, David Valcárcel	2013	32

About Pere Barba

Pere Barba is a scholar working on Hematology, Transplantation, Oncology, Genetics and Pathology and Forensic Medicine, having authored 90 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (38 papers), CAR-T cell therapy research (25 papers), Acute Lymphoblastic Leukemia research (19 papers), Acute Myeloid Leukemia Research (18 papers), Cytomegalovirus and herpesvirus research (12 papers), Lymphoma Diagnosis and Treatment (11 papers), Immune Cell Function and Interaction (10 papers) and Renal Transplantation Outcomes and Treatments (8 papers). The work is most often cited by research in Hematology (709 citations), Transplantation (89 citations), Oncology (826 citations), Genetics (186 citations) and Pathology and Forensic Medicine (201 citations). Pere Barba has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include David Valcárcel, Rodrigo Martino, Jorge Sierra, José Luís Piñana, Salut Brunet, Javier Briones, Anna Sureda, Guillermo Ortí, Julio Delgado and Gloria Iacoboni. Their work appears in journals such as Biology of Blood and Marrow Transplantation, Bone Marrow Transplantation, Blood, Cancer and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact